 | • レポートコード：GIR-2104Z11943 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、網膜症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。網膜症治療の種類別市場規模（加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・網膜症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：ALLERGAN、AbbVie、Alimera Sciences、Janssen Biotech、Swedish Orphan Biovitrum、Roche、Bristol-Myers Squibb、Genzyme、Genentech、OCULAR THERAPEUTIX、Bausch & Lomb、UCBCares ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：加齢性黄斑変性症、糖尿病性網膜症、眼の炎症性疾患（ブドウ膜炎）、黄斑円孔 ・用途別分析2016年-2026年：病院、診療所、その他 ・網膜症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・網膜症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・網膜症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・網膜症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・網膜症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Retinal Disorders Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Retinal Disorders Therapy size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Retinal Disorders Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Retinal Disorders Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Retinal Disorders Therapy
1.2 Classification of Retinal Disorders Therapy by Type
1.2.1 Overview: Global Retinal Disorders Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Retinal Disorders Therapy Revenue Market Share by Type in 2020
1.2.3 Age Related Macular Degeneration
1.2.4 Diabetic Retinopathy
1.2.5 Ocular Inflammatory Disease (Uveitis)
1.2.6 Macular Hole
1.3 Global Retinal Disorders Therapy Market by Application
1.3.1 Overview: Global Retinal Disorders Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Disorders Therapy Market Size & Forecast
1.5 Global Retinal Disorders Therapy Market Size and Forecast by Region
1.5.1 Global Retinal Disorders Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Retinal Disorders Therapy Market Size by Region, (2016-2021)
1.5.3 North America Retinal Disorders Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Retinal Disorders Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Retinal Disorders Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Retinal Disorders Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Retinal Disorders Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Disorders Therapy Market Drivers
1.6.2 Retinal Disorders Therapy Market Restraints
1.6.3 Retinal Disorders Therapy Trends Analysis
2 Company Profiles
2.1 ALLERGAN
2.1.1 ALLERGAN Details
2.1.2 ALLERGAN Major Business
2.1.3 ALLERGAN Retinal Disorders Therapy Product and Solutions
2.1.4 ALLERGAN Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 ALLERGAN Recent Developments and Future Plans
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Retinal Disorders Therapy Product and Solutions
2.2.4 AbbVie Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AbbVie Recent Developments and Future Plans
2.3 Alimera Sciences
2.3.1 Alimera Sciences Details
2.3.2 Alimera Sciences Major Business
2.3.3 Alimera Sciences Retinal Disorders Therapy Product and Solutions
2.3.4 Alimera Sciences Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Alimera Sciences Recent Developments and Future Plans
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech Retinal Disorders Therapy Product and Solutions
2.4.4 Janssen Biotech Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Janssen Biotech Recent Developments and Future Plans
2.5 Swedish Orphan Biovitrum
2.5.1 Swedish Orphan Biovitrum Details
2.5.2 Swedish Orphan Biovitrum Major Business
2.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Product and Solutions
2.5.4 Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Swedish Orphan Biovitrum Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Retinal Disorders Therapy Product and Solutions
2.6.4 Roche Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business
2.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Product and Solutions
2.7.4 Bristol-Myers Squibb Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.8 Genzyme
2.8.1 Genzyme Details
2.8.2 Genzyme Major Business
2.8.3 Genzyme Retinal Disorders Therapy Product and Solutions
2.8.4 Genzyme Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Genzyme Recent Developments and Future Plans
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business
2.9.3 Genentech Retinal Disorders Therapy Product and Solutions
2.9.4 Genentech Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genentech Recent Developments and Future Plans
2.10 OCULAR THERAPEUTIX
2.10.1 OCULAR THERAPEUTIX Details
2.10.2 OCULAR THERAPEUTIX Major Business
2.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Product and Solutions
2.10.4 OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 OCULAR THERAPEUTIX Recent Developments and Future Plans
2.11 Bausch & Lomb
2.11.1 Bausch & Lomb Details
2.11.2 Bausch & Lomb Major Business
2.11.3 Bausch & Lomb Retinal Disorders Therapy Product and Solutions
2.11.4 Bausch & Lomb Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Bausch & Lomb Recent Developments and Future Plans
2.12 UCBCares
2.12.1 UCBCares Details
2.12.2 UCBCares Major Business
2.12.3 UCBCares Retinal Disorders Therapy Product and Solutions
2.12.4 UCBCares Retinal Disorders Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 UCBCares Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Retinal Disorders Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinal Disorders Therapy Players Market Share
3.2.2 Top 10 Retinal Disorders Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Retinal Disorders Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Retinal Disorders Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Retinal Disorders Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Retinal Disorders Therapy Revenue Market Share by Application (2016-2021)
5.2 Retinal Disorders Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Retinal Disorders Therapy Revenue by Type (2016-2026)
6.2 North America Retinal Disorders Therapy Revenue by Application (2016-2026)
6.3 North America Retinal Disorders Therapy Market Size by Country
6.3.1 North America Retinal Disorders Therapy Revenue by Country (2016-2026)
6.3.2 United States Retinal Disorders Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Retinal Disorders Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Retinal Disorders Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Retinal Disorders Therapy Revenue by Type (2016-2026)
7.2 Europe Retinal Disorders Therapy Revenue by Application (2016-2026)
7.3 Europe Retinal Disorders Therapy Market Size by Country
7.3.1 Europe Retinal Disorders Therapy Revenue by Country (2016-2026)
7.3.2 Germany Retinal Disorders Therapy Market Size and Forecast (2016-2026)
7.3.3 France Retinal Disorders Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Retinal Disorders Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Retinal Disorders Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Retinal Disorders Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Retinal Disorders Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Region
8.3.1 Asia-Pacific Retinal Disorders Therapy Revenue by Region (2016-2026)
8.3.2 China Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8.3.5 India Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Retinal Disorders Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Retinal Disorders Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Retinal Disorders Therapy Revenue by Type (2016-2026)
9.2 South America Retinal Disorders Therapy Revenue by Application (2016-2026)
9.3 South America Retinal Disorders Therapy Market Size by Country
9.3.1 South America Retinal Disorders Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Retinal Disorders Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Retinal Disorders Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Retinal Disorders Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Retinal Disorders Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Country
10.3.1 Middle East & Africa Retinal Disorders Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Retinal Disorders Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Retinal Disorders Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Retinal Disorders Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Retinal Disorders Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Retinal Disorders Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Retinal Disorders Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Retinal Disorders Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Retinal Disorders Therapy Revenue Market Share by Region (2021-2026)
Table 6. ALLERGAN Corporate Information, Head Office, and Major Competitors
Table 7. ALLERGAN Major Business
Table 8. ALLERGAN Retinal Disorders Therapy Product and Solutions
Table 9. ALLERGAN Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AbbVie Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Major Business
Table 12. AbbVie Retinal Disorders Therapy Product and Solutions
Table 13. AbbVie Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Alimera Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Alimera Sciences Major Business
Table 16. Alimera Sciences Retinal Disorders Therapy Product and Solutions
Table 17. Alimera Sciences Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Janssen Biotech Corporate Information, Head Office, and Major Competitors
Table 19. Janssen Biotech Major Business
Table 20. Janssen Biotech Retinal Disorders Therapy Product and Solutions
Table 21. Janssen Biotech Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Swedish Orphan Biovitrum Corporate Information, Head Office, and Major Competitors
Table 23. Swedish Orphan Biovitrum Major Business
Table 24. Swedish Orphan Biovitrum Retinal Disorders Therapy Product and Solutions
Table 25. Swedish Orphan Biovitrum Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Retinal Disorders Therapy Product and Solutions
Table 29. Roche Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 31. Bristol-Myers Squibb Major Business
Table 32. Bristol-Myers Squibb Retinal Disorders Therapy Product and Solutions
Table 33. Bristol-Myers Squibb Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Genzyme Corporate Information, Head Office, and Major Competitors
Table 35. Genzyme Major Business
Table 36. Genzyme Retinal Disorders Therapy Product and Solutions
Table 37. Genzyme Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genentech Corporate Information, Head Office, and Major Competitors
Table 39. Genentech Major Business
Table 40. Genentech Retinal Disorders Therapy Product and Solutions
Table 41. Genentech Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. OCULAR THERAPEUTIX Corporate Information, Head Office, and Major Competitors
Table 43. OCULAR THERAPEUTIX Major Business
Table 44. OCULAR THERAPEUTIX Retinal Disorders Therapy Product and Solutions
Table 45. OCULAR THERAPEUTIX Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Bausch & Lomb Corporate Information, Head Office, and Major Competitors
Table 47. Bausch & Lomb Major Business
Table 48. Bausch & Lomb Retinal Disorders Therapy Product and Solutions
Table 49. Bausch & Lomb Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. UCBCares Corporate Information, Head Office, and Major Competitors
Table 51. UCBCares Major Business
Table 52. UCBCares Retinal Disorders Therapy Product and Solutions
Table 53. UCBCares Retinal Disorders Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Retinal Disorders Therapy Revenue (USD Million) by Players (2019-2021)
Table 55. Global Retinal Disorders Therapy Revenue Share by Players (2019-2021)
Table 56. Breakdown of Retinal Disorders Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Retinal Disorders Therapy Players Head Office, Products and Services Provided
Table 58. Retinal Disorders Therapy Mergers & Acquisitions in the Past Five Years
Table 59. Retinal Disorders Therapy New Entrants and Expansion Plans
Table 60. Global Retinal Disorders Therapy Revenue (USD Million) by Type (2016-2021)
Table 61. Global Retinal Disorders Therapy Revenue Share by Type (2016-2021)
Table 62. Global Retinal Disorders Therapy Revenue Forecast by Type (2021-2026)
Table 63. Global Retinal Disorders Therapy Revenue by Application (2016-2021)
Table 64. Global Retinal Disorders Therapy Revenue Forecast by Application (2021-2026)
Table 65. North America Retinal Disorders Therapy Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Retinal Disorders Therapy Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Retinal Disorders Therapy Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Retinal Disorders Therapy Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Retinal Disorders Therapy Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Retinal Disorders Therapy Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Retinal Disorders Therapy Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Retinal Disorders Therapy Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Retinal Disorders Therapy Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Retinal Disorders Therapy Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Retinal Disorders Therapy Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Retinal Disorders Therapy Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Retinal Disorders Therapy Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Retinal Disorders Therapy Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Retinal Disorders Therapy Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Retinal Disorders Therapy Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Retinal Disorders Therapy Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Retinal Disorders Therapy Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Retinal Disorders Therapy Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Retinal Disorders Therapy Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Retinal Disorders Therapy Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Retinal Disorders Therapy Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Retinal Disorders Therapy Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Retinal Disorders Therapy Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Retinal Disorders Therapy Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Retinal Disorders Therapy Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Retinal Disorders Therapy Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Retinal Disorders Therapy Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Retinal Disorders Therapy Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Retinal Disorders Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Retinal Disorders Therapy Picture
Figure 2. Global Retinal Disorders Therapy Revenue Market Share by Type in 2020
Figure 3. Age Related Macular Degeneration
Figure 4. Diabetic Retinopathy
Figure 5. Ocular Inflammatory Disease (Uveitis)
Figure 6. Macular Hole
Figure 7. Retinal Disorders Therapy Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Retinal Disorders Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Retinal Disorders Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Retinal Disorders Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Retinal Disorders Therapy Revenue Market Share by Region in 2020
Figure 15. North America Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Retinal Disorders Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Retinal Disorders Therapy Market Drivers
Figure 20. Retinal Disorders Therapy Market Restraints
Figure 21. Retinal Disorders Therapy Market Trends
Figure 22. ALLERGAN Recent Developments and Future Plans
Figure 23. AbbVie Recent Developments and Future Plans
Figure 24. Alimera Sciences Recent Developments and Future Plans
Figure 25. Janssen Biotech Recent Developments and Future Plans
Figure 26. Swedish Orphan Biovitrum Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 29. Genzyme Recent Developments and Future Plans
Figure 30. Genentech Recent Developments and Future Plans
Figure 31. OCULAR THERAPEUTIX Recent Developments and Future Plans
Figure 32. Bausch & Lomb Recent Developments and Future Plans
Figure 33. UCBCares Recent Developments and Future Plans
Figure 35. Global Retinal Disorders Therapy Revenue Share by Players in 2020
Figure 36. Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Retinal Disorders Therapy Revenue Market Share in 2020
Figure 38. Global Top 10 Players Retinal Disorders Therapy Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Retinal Disorders Therapy Revenue Share by Type in 2020
Figure 41. Global Retinal Disorders Therapy Market Share Forecast by Type (2021-2026)
Figure 42. Global Retinal Disorders Therapy Revenue Share by Application in 2020
Figure 43. Global Retinal Disorders Therapy Market Share Forecast by Application (2021-2026)
Figure 44. North America Retinal Disorders Therapy Sales Market Share by Type (2016-2026)
Figure 45. North America Retinal Disorders Therapy Sales Market Share by Application (2016-2026)
Figure 46. North America Retinal Disorders Therapy Revenue Market Share by Country (2016-2026)
Figure 47. United States Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Retinal Disorders Therapy Sales Market Share by Type (2016-2026)
Figure 51. Europe Retinal Disorders Therapy Sales Market Share by Application (2016-2026)
Figure 52. Europe Retinal Disorders Therapy Revenue Market Share by Country (2016-2026)
Figure 53. Germany Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Retinal Disorders Therapy Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Retinal Disorders Therapy Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Retinal Disorders Therapy Revenue Market Share by Region (2016-2026)
Figure 61. China Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Retinal Disorders Therapy Sales Market Share by Type (2016-2026)
Figure 68. South America Retinal Disorders Therapy Sales Market Share by Application (2016-2026)
Figure 69. South America Retinal Disorders Therapy Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Retinal Disorders Therapy Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Retinal Disorders Therapy Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Retinal Disorders Therapy Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Retinal Disorders Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の網膜障害治療市場規模・現状・予測（2021年-2027年） Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectio…- 世界の黄斑変性症（AMD）・その他網膜疾患市場規模・現状・予測（2021年-2027年） Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands. Market Analysis and Insights: Global…
- 世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の網膜バイオシミラー市場 2021：企業別、地域別、種類・用途別 The Retinal Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の網膜静脈閉塞症治療薬市場規模・現状・予測（2021年-2027年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…